An Iranian official said the country has set up a national research laboratory on primates as part of efforts to develop ...

Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.

– Proceeds to be used to complete clinical proof-of-concept trial for lead candidate, RNDP-001, for the treatment of Parkinson’s disease – – Financing co-led by Alaska Permanent Fund Corporation, Cure ...

For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

Chronic conditions affect over 130 million Americans—nearly half the population—including arthritis, MS, ALS, autism, and age-related decline. While conventional treatments often only manage symptoms, ...

Albert HiuKa Fok receives funding from FRQS. Sabrina Chierzi does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has ...

The Xu laboratory works on developing human stem cell models to study the underlying mechanisms of human neurological disorders, such as Alzheimer's disease, and apply these models for drug screening.